Fundraising FoxY-Prime
Malvern, US · 4 known investors
Find your way into Y-Prime
Sign up to see every warm intro you have to Y-Prime
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Y-Prime team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.
Founders & leadership
Board
Investors · 4
How we know: Flexpoint Ford's portfolio page · Not right? Tell us
How we know: Gray Ventures's portfolio page · Not right? Tell us
How we know: Topmark Partners's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 3 rounds · 2014–2017
▶$2.1MraisedNov 2017 · 2 investors · Other TechnologyRule 506(b)
- JAMES WALKERDirector
- MARK MAIETTAExecutive Officer
- SEAN BARKMANDirector
- MATTHEW RICEDirector
- SHAWN BLACKBURNExecutive Officer, Director
- JAIME COOKExecutive Officer
- TRAVIS MILKSDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMar 2016 · 2 investors · OtherRule 506(b)
- Elizabeth TALLETTDirector
- Richard GASTINEAUDirector
- Jaime COOKExecutive Officer, Director
- Matthew RICEDirector
- Paul BLAKEDirector
- Shawn BLACKBURNExecutive Officer, Director
- James WALKERDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedOct 2014 · 2 investors · OtherRule 506(b)
- Matthew RiceDirector
- Richard GastineauDirector
- Elizabeth TallettDirector
- James PuseyDirector
- Paul BlakeDirector
- Shawn BlackburnExecutive Officer, Director
- Jaime CookExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Sales commissions
- $50K
- Placement agents
- Centerstone Partners, LLC
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Y-Prime do?
- YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.
- Who are Y-Prime's investors?
- Y-Prime's investors include Flexpoint Ford, Gray Ventures, Topmark Partners, Ballast Point Ventures.
- How much funding has Y-Prime raised?
- Y-Prime has disclosed $6.6M raised across 3 rounds.
- Where is Y-Prime headquartered?
- Y-Prime is headquartered in Malvern, US.